Colistin dose for sepsis

1. Al-lawama M, Badran E, Khuri-Bulos N. Neonatal gram-negative sepsis in a tertiary hospital in Jordan: when fever means multidrug resistance. Pediat Therapeut. 2014;4:212.

   Google Scholar 

2. Mavroidi A, Liakopoulos A, Gounaris A, Goudesidou M, Gaitana K, Miriagou V, et al. Successful control of a neonatal outbreak caused mainly by ST20multidrug-resistant SHV-5-producing Klebsiella pneumoniae, Greece. BMC Pediatr. 2014;17[14]:105.

   Article  Google Scholar 

3. Hasan B, Perveen K, Olsen B, Zahra R. Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan. J Med Microbiol. 2014;63:50–5.

   Article  CAS  PubMed  Google Scholar 

4. Tsai MH, Chu SM, Hsu JF, Lien R, Huang HR, Chiang MC, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics. 2014;133[2]:e322–9.

   Article  PubMed  Google Scholar 

5. Litzow JM, Gill CJ, Mantaring JB, Fox MP, MacLeod WB, Mendoza M, et al. High frequency of multidrug-resistant gram-negative rods in 2 neonatal intensive care units in the Philippines. Infect Control Hosp Epidemiol. 2009;30[6]:543–9.

   Article  PubMed  Google Scholar 

6. Tsai MH, Chu SM, Hsu JF, Lien R, Huang HR, Chiang MC, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics. 2014;133[2]:e322–9.

   Article  PubMed  Google Scholar 

7. Chang PY, Hsueh PR, Wu PS, Chan PC, Yang TT, Lu CY, et al. Multidrug-resistant Acinetobacter baumannii isolates in pediatric patients of a university hospital in Taiwan. J Microbiol Immunol Infect. 2007;40[5]:406–10.

   PubMed  Google Scholar 

8. Sehgal R, Gaind R, Chellani H, Agarwal P. Extended-spectrum beta lactamase-producing gram-negative bacteria: clinical profile and outcome in a neonatal intensive care unit. Ann Trop Paediatr. 2007;27[1]:45–54.

   Article  PubMed  Google Scholar 

9. Thatrimontrichai A, Apisarnthanarak A, Chanvitan P, Janjindamai W, Dissaneevate S, Maneenil G. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study. Pediatr Infect Dis J. 2013;32[2]:140–5.

   Article  PubMed  Google Scholar 

10. Celebi S, Hacimustafaoglu M, Koksal N, Ozkan H, Cetinkaya M. Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients. Pediatr Int. 2010;52[3]:410–4.

    Article  CAS  PubMed  Google Scholar 

11. Izadpanah M, Khalili H. Antibiotic regimens for treatment of infections due to multidrug-resistant gram-negative pathogens: an evidence-based literature review. J Res Pharm Pract. 2015;4[3]:105–14.

    PubMed Central  Article  PubMed  Google Scholar 

12. Alan S, Yildiz D, Erdeve O, Cakir U, Kahvecioglu D, Okulu E, et al. Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii. Am J Perinatol. 2014;31[12]:1079–86.

    Article  PubMed  Google Scholar 

13. Jajoo M, Kumar V, Jain M, Kumari S, Manchanda V. Intravenous Colistin administration in neonates. Pediatr Infect Dis J. 2011;30[3]:218–21.

    Article  PubMed  Google Scholar 

14. Iosifidis E, Antachopoulos C, Ioannidou M, Mitroudi M, Sdougka M, Drossou-Agakidou V, et al. Colistin administration to pediatric and neonatal patients. Eur J Pediatr. 2010;169[7]:867–74.

    Article  CAS  PubMed  Google Scholar 

15. Lee YJ, Wi YM, Kwon YJ, Kim SR, Chang SH, Cho S. Association between colistin dose and development of nephrotoxicity. Crit Care Med. 2015;43[6]:1187–93.

    Article  CAS  PubMed  Google Scholar 

16. Ozkaya-Parlakay A, Kara A, Cengiz AB. Increased risk of nephrotoxicity: side effect of Colistin use in paediatric patients. Int J Antimicrob Agents. 2015;45[3]:327.

    Article  CAS  PubMed  Google Scholar 

17. Sowa J, Tsuruta D, Kobayashi H, Ishii M. Allergic contact dermatitis caused by Colistin sulfate & bacitracin. Ann Intern Med. 1970;72[6]:857–68.

    Article  Google Scholar 

18. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970;72[6]:857–68.

    Article  CAS  PubMed  Google Scholar 

19. Alothman GA, Ho B, Alsaadi MM, Ho SL, O’Drowsky L, Louca E, et al. Bronchial constriction and inhaled Colistin in cystic fibrosis. Chest. 2005;127[2]:522–9.

    Article  CAS  PubMed  Google Scholar 

20. Leong KW, Ong S, Chee HL, Lee W, Kwa AL. Hypersensitivity pneumonitis due to high-dose Colistin aerosol therapy. Int J Infect Dis. 2010;14[11]:e1018–9.

    Article  CAS  PubMed  Google Scholar 

21. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970;72[6]:857–68.

    Article  CAS  PubMed  Google Scholar 

Page 2